Bellevue Group AG (LON:0QLZ)
London
· Delayed Price · Currency is GBP · Price in CHF | Market Cap | 97.69M |
| Revenue (ttm) | 62.14M |
| Net Income (ttm) | 8.07M |
| Shares Out | n/a |
| EPS (ttm) | 0.61 |
| PE Ratio | 12.10 |
| Forward PE | n/a |
| Dividend | 0.61 (7.24%) |
| Ex-Dividend Date | Mar 20, 2025 |
| Volume | 301 |
| Average Volume | 929 |
| Open | 8.66 |
| Previous Close | 8.68 |
| Day's Range | 8.46 - 8.66 |
| 52-Week Range | 8.34 - 38.00 |
| Beta | 0.97 |
| RSI | 18.43 |
| Earnings Date | Jul 24, 2025 |
About Bellevue Group AG
Bellevue Group AG provides asset management services in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid caps, and private equity strategies; and multi asset, bonds, and alternatives. In addition, the company offers investment funds, as well as investment solutions for institutional, intermediary and private... [Read more]
Financial Performance
In 2024, Bellevue Group AG's revenue was 70.50 million, a decrease of -13.93% compared to the previous year's 81.91 million. Earnings were 9.16 million, a decrease of -39.83%.
Financial numbers in CHF Financial StatementsNews
Bellevue Gold flags takeover talk after bad hedges force $156m raise
BGL ASX: Gold miner Bellevue flags takeover interest after $156m equity raise
Bellevue misses gold boom as share uncertainty continues
A West Australian gold miner has failed to capitalise on record prices after low-quality ore prompts looming downgrade.